Etiology and evolution of bacterial meningitis in a pediatric center;Etiologia e evolução das meningites bacterianas em centro de pediatria

Jornal de Pediatria

Volumn 78, Issue 1, 2002, Pages 24-30

  Romanelli, Roberta Maia C ^a,c   Araújo, Claudete A ^a   Dias, Miriam W ^d   Boucinhas, Fernando ^b   Carvalho, Inácio R ^b   Martins, Nelson R L ^b   Freire, Heliane B M ^a,b  

^a UFMG   (Brazil)

^b FHEMIG   (Brazil)

^c FHEMIG ^*  (Brazil)

^d NONE

Author keywords

Antimicrobial agents; Cerebrospinal fluid; Meningitis

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; GENTAMICIN; PENICILLIN DERIVATIVE; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL MENINGITIS; BACTERIUM CULTURE; CHILD; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; PEDIATRIC HOSPITAL; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0036210363     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.661     Document Type: Article

References (23)

1. a ed. Philadelphia: WB Saunders; 1998. p.400-29.
2. Saez-Llorens X, McCracken Jr GH. Antimicrobial and anti-inflammatory treatment of bacterial meningitis. Infect Dis Clin North Am 1999; 13: 619-35.
3. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med 1997;336: 708-16.
4. Wubbel L, McCracken GH. Management of Bacterial Meningitis:1998. Pediatrics in Review 1998; 19(3): 78-84.
5. Forleo-Neto E, Oliveira CF, Maluf EMCP, et al. Decrease point prevalence of Haemophilus influenza Type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5 years old with Hib polyribosylribitol phosphate polysaccharide - tetanus toxoid conjugate vaccine in combination with diphtheria - tetanus toxoids - pertussis vaccine. J Infect Dis 1999; 180 (4): 1153-8.
6. Ministério da Saúde. Fundação Nacional de Saúde. Grupo Técnico em Meningite - 2000.
7. Gold R. Epidemiology of bacterial meningitis. Infect Dis Clin North Am 1999; 13: 515-25.
8. Eskola J, Antila M. Pneumococcal conjugate vaccines. Pediatr Infect Dis J 1999; 18(6):543-51.
9. Center of Diseases Control and Prevention. Childhood Immunization Schedule. Morbidity and Mortality Weekly Report 2001; 50(1): 7-10.
10. Dawson KG, Emerson JC, Burns JL. Fifteen years of experience with bacterial meningitis. Pediatr Infect Dis J 1999; 18(9): 816-22.
11. Committee on Infectious Diseases. American Academy of Pediatrics. Therapy for children with invasive pneumococcal infections. Pediatrics 1997; 99(2):289-99.
12. Freire LMS. Tratamento de suporte das meningites bacterianas na infância. Rev Paul Pediatria 1998; 16(2): 104-11.
13. Peltola H. Controversies in the management of childhood meningitis. J Med Microbiol 1997; 46 (11): 901-2.
14. Peltola H, Anttila M, Renkonen OV. Randomised comparison of chloramphenicol, ampicillin, cefotaxime and ceftriaxone for childhood bacterial meningitis. Lancet 1989; I: 1281-87.
15. Campos CEOP, Santos NNQ, Takahashi MN, Kawamura IE, Damião SV, Kushnaroff TM, et al. Aspectos dos líquidos cefalorraquidianos nas meningites bacterianas. Rev Soc Bras Med Trop 1994; 27 (2): 87-91.
16. a ed. St Louis: Mosby; 1998. p.265-79.
17. a ed. Rio de Janeiro: MEDSI; 2000. p.557-70.
18. a ed. 1996. p.953-59.
19. Tesoro LJ, Selbst SM. Factors affecting outcome in meningococcal infections. AJDC 1991; 145:218-20.
20. Malley R, Inkelis SH, Coelho P, Huskins WC, Kuppermann N. Cerebrospinal fluid pleocytosis and prognosis in invasive meningococcal disease in children. Pediatr Infect Dis J 1998; 17(10): 855-59.
21. a ed. Philadelphia: Churchill Livingstone; 2000. p. 959-96.
22. Kaplan SL, Mason EO, Barson WJ, et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics 1998;102(3): 538-45.
23. Brandileone MCC, Di Fabio JL, Vieira VSD, Zanella RC, Casagrande ST, Pignatari AC, et al. Geographic distribution of penicillin resistance of Streptococcus pneumoniae in Brazil: genetic relatedness. Microbial Drug Resistance 1998; 4(3):209-16.